Table 1 Characteristics of 125 patients with pancreatic cancer

Mean age ± SD, years (range)

60.6 ± 8.5 (33–76)

Gender, n (%)

 Male

72 (57.6%)

 Female

53 (42.4%)

Location in pancreas, n (%)

 Head/neck

64 (51.2%)

 Body/tail

61 (49.8%)

Resectability of pancreatic cancer, n (%)

 Resectable

55 (44.0%)

 Borderline resectable

54 (43.2%)

 Locally advanced

16 (12.8%)

Histopathologic features of mass, n (%)

 Ductal adenocarcinoma

114 (91.2%)

 Adenosquamous carcinoma

9 (7.2%)

 Mucinous noncystic carcinoma

1 (0.8%)

 Undifferentiated carcinoma

1 (0.8%)

Tumor resection margin status, n (%)

 R0

93 (74.4%)

 R1

32 (25.6%)

Y of surgery

2019–2022

N stage, n (%)

 NX

1 (0.8%)

 N0

63 (50.4%)

 N1

49 (39.2%)

 N2

12 (9.6%)

Tumor regression grade, n (%)^a

 0

3 (2.4%)

 1

12 (9.6%)

 2

73 (58.4%)

 3

37 (29.6%)